THYROCARE — Thyrocare Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹33.49bn
- IN₹33.02bn
- IN₹5.27bn
- 98
- 10
- 82
- 74
Annual cashflow statement for Thyrocare Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,381 | 1,465 | 1,525 | 2,279 | 874 |
| Depreciation | |||||
| Non-Cash Items | -27.3 | 2.2 | -56.7 | -124 | 259 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -612 | -110 | -611 | -1,360 | -227 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,003 | 1,676 | 1,160 | 1,134 | 1,293 |
| Capital Expenditures | -403 | -99 | -283 | -378 | -437 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 287 | 109 | -220 | 143 | 46.6 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -116 | 9.5 | -502 | -236 | -390 |
| Financing Cash Flow Items | -63.1 | -285 | -7.1 | -47.5 | -13.3 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -936 | -1,648 | -616 | -894 | -862 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -49.1 | 38 | 42.4 | 4.3 | 41.4 |